95 related articles for article (PubMed ID: 16201910)
21. Hybridization of antisense reagents to RNA.
Sohail M; Southern EM
Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
[TBL] [Abstract][Full Text] [Related]
22. Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices.
Stull RA; Taylor LA; Szoka FC
Nucleic Acids Res; 1992 Jul; 20(13):3501-8. PubMed ID: 1352874
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of bacterial RNase P RNA as a drug target.
Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
[TBL] [Abstract][Full Text] [Related]
24. Guanine-tethered antisense oligonucleotides as synthetic riboregulators.
Hagihara M
Methods Mol Biol; 2014; 1111():197-207. PubMed ID: 24549621
[TBL] [Abstract][Full Text] [Related]
25. Transfection protocol for antisense oligonucleotides affects uniformity of transfection in cell culture and efficiency of mRNA target reduction.
Reed CA; Peralta ER; Wenrich LM; Wong CA; Bennett CF; Freier S; Lollo B
Oligonucleotides; 2005; 15(1):12-22. PubMed ID: 15788897
[TBL] [Abstract][Full Text] [Related]
26. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
[TBL] [Abstract][Full Text] [Related]
27. Selection of antisense oligonucleotides based on multiple predicted target mRNA structures.
Bo X; Lou S; Sun D; Shu W; Yang J; Wang S
BMC Bioinformatics; 2006 Mar; 7():122. PubMed ID: 16526963
[TBL] [Abstract][Full Text] [Related]
28. Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation.
Shao Y; Wu Y; Chan CY; McDonough K; Ding Y
Nucleic Acids Res; 2006; 34(19):5660-9. PubMed ID: 17038332
[TBL] [Abstract][Full Text] [Related]
29. RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts.
Scherr M; Rossi JJ; Sczakiel G; Patzel V
Nucleic Acids Res; 2000 Jul; 28(13):2455-61. PubMed ID: 10871393
[TBL] [Abstract][Full Text] [Related]
30. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
31. Theoretical and experimental selection parameters for HBV-directed antisense RNA are related to increased RNA-RNA annealing.
Patzel V; zu Putlitz J; Wieland S; Blum HE; Sczakiel G
Biol Chem; 1997 Jun; 378(6):539-43. PubMed ID: 9224935
[TBL] [Abstract][Full Text] [Related]
32. Antisense micF RNA and 5'-UTR of the target ompF RNA: phylogenetic conservation of primary and secondary structures.
Delihas N
Nucleic Acids Symp Ser; 1997; (36):33-5. PubMed ID: 9478198
[TBL] [Abstract][Full Text] [Related]
33. Free energy minimization to predict RNA secondary structures and computational RNA design.
Churkin A; Weinbrand L; Barash D
Methods Mol Biol; 2015; 1269():3-16. PubMed ID: 25577369
[TBL] [Abstract][Full Text] [Related]
34. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
[TBL] [Abstract][Full Text] [Related]
35. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
36. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
[TBL] [Abstract][Full Text] [Related]
37. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
[TBL] [Abstract][Full Text] [Related]
38. Rapid identification of antisense mRNA-expressing clones using strand-specific RT-PCR.
Cummings M; McGurk C; Masters JR
Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):115-7. PubMed ID: 12804038
[TBL] [Abstract][Full Text] [Related]
39. In vitro selection of antisense oligonucleotides targeted to a hairpin structure.
Mishra RK; Toulmé JJ
C R Acad Sci III; 1994 Nov; 317(11):977-82. PubMed ID: 7882142
[TBL] [Abstract][Full Text] [Related]
40. Simplifying the probe set.
Moore P
Nature; 2005 May; 435(7039):238. PubMed ID: 15889103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
